Skip to content
OpenCapital
Get started

Pfizer PFE Alliance revenues

Alliance revenues at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$94M+6.8%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$321M+1.9%
Cencora logo
CencoraCOR
$6.52B+12.9%
Esperion Therapeutics logo
Esperion TherapeuticsESPR
$36.71M+22.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$1.9B+24.1%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$3.5M-60.7%

Segments

By product

See full
Total Alliance revenues$2.34B+10.7%

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$134.91B-1.0%
Enterprise value$197.57B+0.7%
P/E11.1×—
P/S2.1×-0.1×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%—
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%—
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's alliance revenues.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's alliance revenues?
Pfizer (PFE) reported alliance revenues of $2.34B in Q1 2026.
How has Pfizer's alliance revenues changed year-over-year?
Pfizer's alliance revenues increased by 10.7% year-over-year, from $2.11B to $2.34B.
What is the long-term trend for Pfizer's alliance revenues?
Over 4 years (2021 to 2025), Pfizer's alliance revenues has grown at a 4.9% compound annual growth rate (CAGR), from $7.65B to $9.27B.
What does alliance revenues mean?
Revenue generated through collaborative arrangements, co-promotion agreements, or profit-sharing partnerships with other pharmaceutical entities. This reflects the income derived from shared commercialization efforts rather than direct sales of proprietary products.